Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry

BACKGROUND: The long-term survival of cancer patients has significantly improved over the past years. Despite their therapeutic efficacy, various cancer therapies are associated with cardiotoxicity. Therefore, timely detection of cardiotoxic adverse events is crucial. However, the clinical assessmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinrichs, Lena, Mrotzek, Simone Maria, Mincu, Raluca-Ileana, Pohl, Julia, Röll, Alina, Michel, Lars, Mahabadi, Amir Abbas, Al-Rashid, Fadi, Totzeck, Matthias, Rassaf, Tienush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248256/
https://www.ncbi.nlm.nih.gov/pubmed/32508657
http://dx.doi.org/10.3389/fphar.2020.00740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248256/
https://www.ncbi.nlm.nih.gov/pubmed/32508657
http://dx.doi.org/10.3389/fphar.2020.00740

Ejemplares similares